Skip to content

DRMA

Dermata Therapeutics, Inc.

NASDAQ · Healthcare · Biotechnology · US

$1.16
−0.01%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
P/E 2026E
P/E 2027E
P/E 2028E
P/S forward
16.42x

Trailing multiples

Trailing twelve months

P/E TTM
PEG TTM
Price / book
1.65x
Price / sales
Price / cash flow
-0.72x

Enterprise value

Enterprise value
$1.3M
EV / sales
EV / EBITDA
-0.16x
EV / EBIT
-0.16x
Market cap
$5.7M

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026